The Border Agency officials warned that the counterfeit erectile dysfunction tablets, which were worth more than £1 million were destined for the black market, contained "potentially harmful chemicals which were likely to have the desired effect."
Clearly these bogus drugs would have gone undetected by their victims until their overall health was negatively impacted. In most cases it seems likely that the victims or their health care provider would not have any idea as to the real cause of their decline.
These isolated seizures are not isolated incidents and demonstrate how prevalent this deadly crime has become in developed countries.
No population is safe from fake medications spreading poor health, disease and death.
Bogus drugs that go to the black market end up in the legitimate supply chain through a variety of sources because of the huge profits realized by the criminals.
We are now seeing trusted health care professionals becoming involved in this deadly trade, lured by the money and the lax regulatory enforcement.
It is imperative that all members of the pharmaceutical supply chain become proactive in deploying solutions and technologies to protect their inventories and consumers from these deadly medications. As this deadly issue accelerates into the developed world, those that make the investment now will save lives and profit from their foresight.
To learn more about anti-counterfeiting solutions, visit: http://www.xstreamsystems.net/.
No comments:
Post a Comment